The Efficacy and Safety of Amyloid Beta‐Directed Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
Anti-Aβ mAbs offer modest clinical benefits, and pose some serious complications, necessitating a cautious approach to their prescription.
Authors
- Hualing Li (ORCID: https://orcid.org/0009-0001-2099-3607)
- Yun Wei (ORCID: https://orcid.org/0009-0002-2886-6503)
Institutions
- Yangzhou University (CN)
Publication Details
- Journal
- Human Psychopharmacology Clinical and Experimental
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/hup.70017
- Citations
- 1
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.16